Articles tagged with Macrophages
Researchers at Johns Hopkins Medicine developed a new mouse model that mimics the effects of red blood cell transfusions on human infants with necrotizing enterocolitis (NEC). The study found that severe anemia increases the risk of NEC after transfusion, and that free hemoglobin can trigger an immune response in the intestine.
Researchers found that whole body vibration increases levels of Alistipes, a bacterium producing short chain fatty acids that decrease inflammation. This shift also improves the balance between macrophages promoting and suppressing inflammation.
Researchers at Stanford University School of Medicine have discovered a new 'don't eat me' signal used by cancer cells to evade immune detection. Blocking this signal allows immune cells to attack and destroy cancer cells in mice implanted with human cancers, providing a potential basis for new anti-cancer therapies.
Researchers have identified a molecule called Gas6 that induces macrophages to clean up cellular debris and reduce inflammation. Boosting Gas6 levels in macrophages has been shown to resolve inflammation in mouse models of acute lung injury, holding promise for treating diseases such as heart disease, cancer, and rheumatoid arthritis.
Researchers at Johns Hopkins Medicine discovered that certain forms of heart disease may result when circulating anti-inflammatory white blood cells fail to properly differentiate into macrophages. Blocking a key protein, IL-17A, permits healthy cardiac function and allows macrophages to protect the heart muscle.
A new study identifies an enzyme critical for normal wound healing in diabetes, suggesting a potential treatment with allopurinol. In diabetic mice, blocking uric acid production improved healing rates.
Research found that extracellular vesicles derived from kids' fat can disrupt cholesterol disposal in various tissues, regardless of weight. The study suggests that fat tissue plays a pivotal role in triggering cardiovascular disease, even before symptoms appear.
Researchers uncover the role of macrophages in causing pelvic pain in endometriosis, potentially leading to new non-hormonal treatments. The discovery was published in The FASEB Journal and found increased production of IGF-1 by macrophages, which encourages nerve growth and activation.
Scientists deciphered how YopO changes its shape to confuse the immune system, disrupting communication and allowing bacteria to evade digestion. Understanding this process may lead to developing targeted, tailor-made substances to inhibit plague pathogens.
In the absence of gasdermin D, caspase-1 induces apoptosis, but not pyroptosis, in macrophages. Caspase family members caspase-3 and caspase-9 are involved in this process. The study suggests that caspase-1 activates Bid, a pro-apoptotic protein, which induces cytochrome c release from mitochondria and subsequent apoptosis.
Researchers used advanced imaging techniques to visualize macrophages in living mice with brain tumors, finding clear morphological and behavioral differences between blood-derived and brain-resident macrophages. Blocking macrophage infiltration improved survival in treated mice.
Scientists at the University of Illinois found that three phenolic compounds in cocoa bean shells can repair damaged mitochondria, block inflammation, and restore insulin sensitivity in white fat cells. The study suggests that consuming these compounds could prevent mitochondrial dysfunction in adipose tissue.
Researchers found that extracellular pathogens like Pseudomonas aeruginosa can enter host cells and induce cell lysis through the type III secretion system. The study reveals a new mechanism of bacterial killing in macrophages.
Scientists have made a breakthrough in understanding how macrophage cells respond to certain bacteria, potentially leading to new treatments for Crohn's Disease. The study found that different types of macrophages exhibit distinct molecular mechanisms when switching off their pro-inflammatory behavior.
Research at MD Anderson Cancer Center discovers a symbiotic circuit between PTEN-deficient glioblastoma cells and macrophages, which creates a mutually supportive relationship. Inhibiting LOX, a novel attractor of macrophages, shrinks tumors and blocks macrophage infiltration.
Under hypoxic conditions, fewer metabolites are produced in the citric acid cycle, reducing bacterial reproduction in macrophages. This discovery provides a new method for pathogen control that doesn't rely on oxygen levels.
Researchers at Virginia Tech have gained a new understanding of the complex interactions between macrophages and fibroblasts as they work together to clean up and repair damaged tissue. The study shows that manipulating the environment around these cells could lead to improved treatments for wounds and tumors.
Researchers identified a new molecular mechanism causing rheumatoid arthritis, finding that death of macrophages triggers the disease. The protein A20 was found to prevent macrophage death and protect against arthritis.
A new study uncovers the presence of 'hidden' microglia in the brain, which show a resemblance to microglia associated with Alzheimer's disease. The researchers hope to find strategies for controlling these immune cells to develop future treatments for neurodegenerative diseases.
Researchers have discovered a potential new treatment for renal fibrosis by selectively activating AT1 receptors on T cells, which may help limit scar formation in the kidney. The study found that activating these receptors mitigates renal fibrogenesis by inhibiting Th1 differentiation and renal accumulation of pro-fibrotic macrophages.
A new study reveals how Salmonella bacteria flip an electric switch within immune cells, causing them to migrate out of the gut and into the bloodstream. This mechanism contributes to the severity of food-borne illnesses, with over 400,000 deaths worldwide each year.
Researchers discovered that HIV-1 forms nanotubes between macrophages in tuberculosis patients, increasing viral transfer and production. This finding provides potential targets for reducing viral load and improving treatment outcomes.
A new study from Cornell University has identified a genetic regulator called SAF that helps HIV-infected macrophages avoid cell death. By blocking SAF, researchers found that infected cells self-destructed while healthy cells remained untouched, presenting a novel angle for potential therapies to selectively eradicate reservoir cells.
A new NIH study found that meningitis can alter the composition of immune cells in the brain's lining, replacing them with cells from outside the meninges and affecting their ability to respond to future infections. The research suggests that infections in the brain can have long-lasting effects on the immune system.
Researchers from Helmholtz Munich used optoacoustic imaging with purple bacteria to detect macrophages in tumors, providing insights into their activity and role in cancer development. This breakthrough enables novel non-invasive technologies for diagnosis and treatment.
Researchers discovered lipid-filled particles (AdExos) released by adipocytes in mice that activate immune function and regulate metabolism. AdExos control the development of immune cells, inducing bone marrow cells to develop into macrophages that digest lipids.
Researchers identified a new type of immune cell called macrophages that play a critical role in heart valve formation and maintenance. These heart-derived macrophages are particularly adept at consuming excess tissue, making them indispensable to the formation and maintenance of healthy valves.
Researchers at the University of Turku developed an immunotherapeutic antibody therapy that re-educates tumour-associated macrophages to activate cytotoxic T cells. The therapy showed promising results in a phase I/II clinical trial, inhibiting cancer progression and increasing activation of killer T cells.
Researchers at Kobe University found that vitamin D signaling fuels the growth of macrophages in bone marrow, leading to myelofibrosis and bone hardening. A low-vitamin D diet can prevent or treat the condition.
Macrophages play a vital role in controlling the processes of nerve repair following damage by secreting repulsive cues. The interaction between Slit3 and Robo1 allows for the migration of Schwann cells and regrowing nerve projections, enabling successful regeneration and recovery of nerve function.
Scientists at MCG are studying a new treatment target for retinal damage, characterized by blood vessel disruption leading to vision loss. They believe the key lies in arginase 1, an enzyme that helps regulate inflammation, which can be either damaging or reparative.
Researchers discovered that kidney-resident macrophages in mice undergo a developmental reprogramming after acute kidney injury, similar to those found in newborn mice. This reprogramming may aid in promoting healing and tissue regeneration, potentially leading to new therapeutic approaches for patients.
Researchers at the University of Pennsylvania School of Medicine have identified a method to fuel macrophages with energy needed to attack and eat cancer cells. By rewiring macrophage metabolism, macrophages can overcome signals that prevent them from attacking tumors, leading to tumor shrinkage and prolonged survival in mice.
Scientists have identified a new role for specialized immune cells called macrophages in regulating blood pressure. By monitoring and regulating the hormone endothelin, these cells help relax blood vessels, significantly lowering blood pressure. The findings could lead to improved treatments for hypertension.
Researchers found that interleukin-6 is involved in the development of severe asthma, a subtype associated with neutrophil accumulation. Blocking this molecule may lead to new treatments for asthma.
Scientists at the Peter Munk Cardiac Centre have discovered that macrophage cells play a crucial role in helping the heart repair and regenerate following a heart attack. The study found that these cells can act in a neo-natal-like state, aiding in tissue growth and development.
Researchers at Duke University Medical Center have identified a key player in bone healing - young macrophage cells and their secreted proteins. Introducing these factors into old mice improves fracture repair, providing a potential new treatment for delayed healing.
Researchers at Children's Hospital Los Angeles discovered that cancer cells use Plasminogen Activator Inhibitor 1 (PAI-1) to manipulate healthy macrophages, changing their behavior from anti-cancer to pro-cancer. This mechanism is associated with more aggressive and difficult-to-treat cancers.
A new study reveals that liver macrophages do not contain infectious forms of HIV and are unlikely to replicate the infection on their own. The findings narrow potential treatment targets for HIV-infected people taking long-term antiretroviral therapy.
Researchers have discovered that macrophage activity is lowered when they sit in tissue between cells, even with pro-inflammatory stimuli present. This mechanism helps prevent unnecessary inflammatory responses in healthy tissues.
Researchers discovered that HSPCs preferentially anchor at venous capillary confluence points guided by VCAM-1+ macrophages. This interaction helps regulate HSPC retention and expansion, providing new insights into the homing process.
A new study reveals that the protein Del-1 plays a vital role in clearing inflammation by connecting dying neutrophils to macrophages. The 'location principle' suggests that homeostatic molecules perform different regulatory functions depending on their location.
Researchers discovered that mitochondria deploy ROS to destroy invading MRSA bacteria by packaging and delivering these molecules to the phagosome, bypassing traditional immune mechanisms. This backup system helps immune cells fight off pathogens with increased effectiveness.
Scientists discover enzyme arginase 1 plays protective role in retinal health by suppressing inflammation and promoting recovery. Administering pegylated arginase 1 reduces inflammation and subsequent damage following reperfusion injury, offering potential new treatment for neurovascular injury.
Researchers discovered that modified LDL particles trigger an immune response in macrophages, leading to chronic inflammation. The study found 27 transcription factors involved in the process, highlighting the importance of inflammation in atherosclerosis pathogenesis.
The study found that pro-inflammatory TNFα and anti-inflammatory CCL18 cytokines are increased in human atherosclerotic lesions, associated with cholesterol accumulation. The expression levels vary across plaque stages, with maximum levels in lipofibrous plaques.
Researchers found that natural killer cells fail to respond to malaria infection in some patients, leading to more severe disease outcomes. By identifying key genes involved, they discovered a potential therapeutic target using poly I:C treatment.
Biomedical engineers at Duke University discovered that immune cells, specifically macrophages, play a critical role in regenerating lab-grown adult muscle tissue. The discovery could lead to new treatments for degenerative muscle diseases and enhance the survival of engineered tissue grafts.
Researchers develop a system using IL-4 nanoparticles to target macrophages, reducing inflammation and promoting muscle fiber regeneration. Mice with injured muscles treated with IL-4 nanoparticles showed improved muscle structure and strength.
New research finds tiny particles of carbon in placentas, suggesting air pollution can affect foetal development. The study reveals that sooty particles from the mother's lungs can reach the placenta via the bloodstream.
Researchers have developed a method to separate infected and uninfected cells, revealing how Zika virus manipulates the human immune system by suppressing gene production in macrophage cells. This approach provides a more accurate account of Zika's effect on macrophages and shows that the virus uses two methods to stop their function.
KU Leuven scientists found long-lived macrophages in mice intestines that can survive for at least eight months, vital for nerve cell survival. These macrophages play a critical role in maintaining intestinal health, and their dysfunction leads to digestive problems.
Researchers demonstrate that a single transplantation of iPSC-derived macrophages into the lungs of mice with herPAP can effectively treat this life-threatening disease. The transplanted macrophages adapt and differentiate to function efficiently, providing long-term therapeutic benefits.
Researchers found that mice infected with hookworms produce super-killer macrophages that are efficient at killing the worms but also cause tissue damage and inflammation. The study reveals that RELMalpha, an immune protein, helps balance immunity and inflammation by downregulating inflammatory responses.
A team of researchers found that LYVE-1 macrophages protect arteries from becoming stiff by interacting with smooth muscle cells and reducing collagen production. The protein is responsible for binding to hyaluronan, facilitating the degradation of collagen.
Researchers found that diabetes medications controlling macrophage metabolism can reduce inflammation and promote wound healing. By regulating energy sources for immune cells, these medications may inhibit the progression of diseases such as obesity and diabetes.
Researchers found that PI3Kγ expression increases during T. cruzi infection, essential for avoiding excessive inflammation and controlling heart parasitemia. The enzyme's absence in macrophages impairs their ability to kill parasites and control inflammation.
Researchers discovered that Mycobacterium tuberculosis uses a toxin to deplete NAD+ in macrophages, leading to necrotic cell death. Adding NAD+ replenishment or mitochondrial function protectants restricted bacterial growth and increased macrophage viability. These findings suggest patient-targeted therapies to treat tuberculosis.
A new PET imaging method evaluates the extent of rheumatoid arthritis inflammation by targeting translocator protein (TSPO) expression in joint lining tissue. The study demonstrates that TSPO PET can image not only synovial macrophages but also activated synovial fibroblasts, a critical process in RA pathogenesis.
Researchers found that Zika virus has a unique ability to ferry the virus throughout the body using macrophage cells, allowing it to bypass natural barriers. This discovery could lead to the development of effective countermeasures to protect people from the virus's devastating effects.